Taking Enzyme Research to New Heights
Almost four years of high altitude climbing and enzyme research concluded on May 22, 2009 when Troy Aupperle, President of Enzymology Research Center, Inc. (ERC) stepped onto the summit of Mt. Everest. Troy’s goal to climb the 7 Summits and set a new American record was thwarted due to both logistical as well as political obstacles. The peaks were completed in 3 years and 312 days making it the 3rd fastest U.S. time and 17th in the world. ERC, Inc. provided both Digestive and Systemic Enzymes that were used in conjunction. The enormous stress on the body to digest food at altitudes above 15,000’ was relieved through taking the Digestive Enzymes with meals. After the two month expedition concluded Troy had lost 14 lbs while the average weight loss exceeded 20 lbs. The Systemic Enzymes contained both Nattokinase and Seaprosidase. A new form of Nattokinase was used to decrease blood viscosity and increase circulation in order to lower the risk of frostbite and speed up acclimatization. Seaprosidase was used to keep the respiratory system free of congestion in order to avoid High Altitude Pulmonary Edema (HAPE). The oxygen content in Troy’s blood averaged 83 while others suffered from Acute Mountain Sickness (AMS) in various stages with levels between 50- 70. “Accomplishing this amazing goal with minimal physical wear-and-tear was made possible by utilizing the full potential of enzymes.” Completing the 7 Summits was Troy’s first step in introducing enzymes to the world. He’s currently writing a book and will be presenting seminars internationally. He has and will continue to prove that you can “reach your peak” with enzymes.
Recent Press:
